Why choose Germany for chemoembolization of the liver?
Access advanced Chemoembolization of the liver solutions in trusted clinics .
The cost of chemoembolization of the liver in Germany typically ranges from $18,000 to $27,000. Prices vary depending on the clinic, the interventional radiologist’s experience, tumor size and location, and the number of treatment sessions needed. In the United States, the average cost is $35,000 (per NCCN). This means chemoembolization in Germany is about 36% less expensive than in the U.S.
German clinics generally include pre-procedure imaging (CT or MRI), the chemoembolization procedure itself, all medications and embolic agents, anesthesia, a short hospital stay (1–3 days), and follow-up imaging. In the U.S., hospital, radiologist, drugs, and post-procedure care are often billed separately. Always confirm what’s included at your chosen clinic.
| Germany | Turkey | Austria | |
| Chemoembolization of the liver | from $18,000 | from $7,500 | from $16,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemoembolization of the liver upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemoembolization of the liver and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemoembolization of the liver journey.
Solingen Municipal Hospital/Academic Hospital of the University of Cologne is among top clinics in Germany according to Focus magazine - one of the most widely circulated German editions. Städtisches Klinikum Solingen is a certified medical institution treating over 60,000 patients per year.
Asklepios Hospital Barmbek is a clinic No. 1 for foreign patients according to the Medical Travel Quality Alliance, the international organization for medical tourism.
The Hospital is a multidisciplinary medical center. It is a part of Asklepios Kliniken, the most significant German hospitals' network.
Asklepios Barmbek specializes in Oncology, Oncohematology, Surgery, and Pulmonology.
80,000 patients from Germany and other countries worldwide receive treatment annually here.
Nordwest Krankenhaus is a multi specialized medical institution, a leading hospital in Germany due to development of innovations, such as 3D ultrasound, anticancer vaccines in targeted therapy. It comprises 5 research institutes and 11 specialized centers.
Asklepios Klinik Altona is a university hospital of Hamburg, one of the oldest medical facilities in Northern Germany. The medical center belongs to the hospitals’ group of Asklepios Kliniken. Asklepios Altona Hamburg specializes in robotic surgery, gastroenterology, abdominal surgery, neurology, and oncology specialties.
95,000 patients get treatment annually here.
Klinikum Bremen-Mitte is a multidisciplinary hospital included in the network of medical centers Gesundheit Nord (Nord Klinik Allianz). Bremen-Mitte specializes in oncology, orthopedics, surgery, neurology, and neurosurgery.
In 2015-2016, Focus magazine, an authoritative German edition, included the hospital in the TOP of the leading medical institutions in Germany. The rating is based on patients’ reviews and doctors’ qualifications.
40,000 patients choose Klinikum Bremen-Mitte for treatment every year.
Day 1: Arrival
Day 2: Consultation and Preperation
Day 3: Chemoembolization Procedure
Day 4: Post-Operation
Week 1: Rehabilitation
Weeks 2-4: Gradual Return to Normal Activities
Week 6: Final Result
Please note that individual recovery times and experiences may vary.
Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.
She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.
Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.